Earnings History Data for Biolase, Inc. (BIOL) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Biolase, Inc.

Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
13-05-2024	AH		BIOL	Biolase, Inc.	5.66	-0.36	0.00	18.00	Biolase GAAP EPS of -$0.36 misses by $0.19, revenue of $10.13M beats by $0.13M [5/13/2024 4:11 PM]	0.1539	-0.03 (-14.93%)	0.16	-0.02 (-13.21%)	0.13 - 23.32	2,642,272	1,920,000	746,521
Biolase GAAP EPS of -$0.36 misses by $0.19, revenue of $10.13M beats by $0.13M [5/13/2024 4:11 PM]
21-03-2024	AH		BIOL	Biolase, Inc.	0.32	-1.76	0.00	-99.99	Biolase GAAP EPS of -$1.76 beats by $0.80, revenue of $13.49M beats by $0.27M [3/21/2024 4:15 PM]	0.1799	0.03 (19.93%)	0.24	0.09 (58.93%)	0.13 - 47.10	77,272,179	4,480,000	51,586,856
Biolase GAAP EPS of -$1.76 beats by $0.80, revenue of $13.49M beats by $0.27M [3/21/2024 4:15 PM]
10-08-2023	AH		BIOL	Biolase, Inc.	7.06	-8.93	0.00	91.00	Biolase Non-GAAP EPS of -$4.24 beats by $1.76, revenue of $14.3M misses by $1.06M [8/10/2023 4:07 PM]	5.32	-0.81 (-13.30%)	5.82	-0.31 (-5.06%)	4.65 - 594.00	114,251	700,000	2,510
Biolase Non-GAAP EPS of -$4.24 beats by $1.76, revenue of $14.3M misses by $1.06M [8/10/2023 4:07 PM]
11-05-2023	AH	4:05 PM ET (May 11)	BIOL	Biolase, Inc.	5.27	-0.18	0.00	-0.81	Biolase GAAP EPS of -$0.18 beats by $0.02, revenue of $10.47M beats by $0.29M [5/11/2023 4:24 PM]	0.2391	0.0 (-0.33%)	0.22	-0.02 (-9.21%)	0.17 - 5.94	2,334,984	2,070,000	113,301
Biolase GAAP EPS of -$0.18 beats by $0.02, revenue of $10.47M beats by $0.29M [5/11/2023 4:24 PM]
28-03-2023	AH	4:05 PM ET (Mar 28)	BIOL	Biolase, Inc.	11.00	-1.28	0.00	-0.75	Biolase GAAP EPS of -$1.28 misses by $0.64, revenue of $14.05M misses by $0.02M [3/28/2023 4:09 PM]	0.3266	-0.07 (-16.75%)	0.36	-0.03 (-6.96%)	0.30 - 9.24	932,096	320,000	26,962
Biolase GAAP EPS of -$1.28 misses by $0.64, revenue of $14.05M misses by $0.02M [3/28/2023 4:09 PM] Biolase stock slides as losses widen [3/29/2023 10:22 AM]
10-11-2022	AH	4:05 PM ET (Nov 10)	BIOL	Biolase, Inc.	12.14	-1.10	0.00	-0.50	Biolase GAAP EPS of -$1.10 misses by $0.26, revenue of $12.01M beats by $1.36M [11/10/2022 4:12 PM]	1.64	0.07 (4.46%)	1.50	-0.07 (-4.46%)	1.40 - 15.12	78,210	60,000	1,433
Biolase GAAP EPS of -$1.10 misses by $0.26, revenue of $12.01M beats by $1.36M [11/10/2022 4:12 PM] BIOLASE DELIVERS 26% REVENUE GROWTH YEAR OVER YEAR IN THIRD QUARTER AND RAISES 2022 FULL YEAR REVENUE GUIDANCE [Nov-10-22 04:05PM]
11-08-2022	AH	4:05 PM ET (Aug 11)	BIOL	Biolase, Inc.	27.85	-0.91	0.00	-0.50	Biolase GAAP EPS of -$0.91, revenue of $12.2M [8/11/2022 4:10 PM]	5.21	-0.32 (-5.83%)	5.95	0.42 (7.55%)	3.30 - 23.48	68,697	50,000	184
Biolase GAAP EPS of -$0.91, revenue of $12.2M [8/11/2022 4:10 PM] BIOLASE DELIVERS 34% REVENUE GROWTH YEAR OVER YEAR IN SECOND QUARTER [Aug-11-22 04:05PM]
12-05-2022	AH	4:05 PM ET (May 12)	BIOL	Biolase, Inc.	25.81	-0.81	0.00	-1.50	Biolase Non-GAAP EPS of -$0.64 misses by $0.14, revenue of $10.17M beats by $1.16M [5/12/2022 4:21 PM]	3.97	0.55 (16.08%)	3.68	0.26 (7.60%)	3.30 - 23.48	79,236	130,000	959
Biolase Non-GAAP EPS of -$0.64 misses by $0.14, revenue of $10.17M beats by $1.16M [5/12/2022 4:21 PM] BIOLASE MAINTAINS GROWTH MOMENTUM AS FIRST QUARTER REVENUE INCREASED 25% YEAR OVER YEAR [May-12-22 04:05PM]
17-03-2022	AH	4:05 PM ET (Mar 17)	BIOL	Biolase, Inc.	49.05	-0.03	-0.03	-0.07	Biolase GAAP EPS of -$0.03, revenue of $12.4M [3/17/2022 4:10 PM]	0.3585	-0.04 (-9.06%)	0.3830	-0.01 (-2.84%)	0.31 - 1.03	4,138,489	2,113,295	9,234
Biolase GAAP EPS of -$0.03, revenue of $12.4M [3/17/2022 4:10 PM] BIOLASE REPORTS CONTINUED GROWTH FOR FOURTH QUARTER AND FULL YEAR 2021 [Mar-17-22 04:05PM]
10-11-2021	AH	4:05 PM ET (Nov 10)	BIOL	Biolase, Inc.	94.86	-0.02	-0.03	-0.21	Biolase EPS beats by $0.01, beats on revenue [11/10/2021 4:12 PM]	0.57	-0.03 (-5.00%)	0.61	0.01 (1.67%)	0.26 - 1.51	4,032,461	2,110,000	65,807
Biolase EPS beats by $0.01, beats on revenue [11/10/2021 4:12 PM] BIOLASE Reports 46% Revenue Growth In 2021 Third Quarter; Demand For Dental Lasers From New Customers Remains High And Continues To Fuel Growth [Nov-10-21 04:05PM]
12-08-2021	AH	4:05 PM ET (Aug 12)	BIOL	Biolase, Inc.	88.74	-0.02	-0.04	-0.12	Biolase EPS beats by $0.04, beats on revenue [8/12/2021 4:10 PM]	0.7957	0.16 (25.98%)	0.93	0.29 (46.58%)	0.24 - 1.51	99,976,799	1,930,000	16,659,766
Biolase EPS beats by $0.04, beats on revenue [8/12/2021 4:10 PM] Biolase gains after forecasting strong near-term outlook [8/12/2021 5:06 PM] BIOLASE Reports Significantly Improved Revenue In Its Second Quarter As Continued High Demand For Dental Lasers From New Customers Fueled Growth [Aug-12-21 04:05PM] Biolase Stock Surges on Strong Third-Quarter Revenue Guidance [Aug-13-21 06:36AM]
13-05-2021	AH	4:05 PM ET (May 13)	BIOL	Biolase, Inc.	93.63	-0.06	-0.05	-0.19	Biolase EPS misses by $0.01, beats on revenue; issues guidance [5/13/2021 4:10 PM]	0.7020	0.12 (21.03%)	0.77	0.19 (31.91%)	0.24 - 1.51	18,911,588	2,850,000	4,970,089
Biolase EPS misses by $0.01, beats on revenue; issues guidance [5/13/2021 4:10 PM] BIOLASE posts Q1 topline beat, provides forecast [5/13/2021 5:00 PM] BIOLASE, Inc. to Host Earnings Call [May-13-21 02:30PM] BIOLASE Reports 70% Revenue Growth In First Quarter 2021; Continued High Demand From New Users For Dental Lasers [May-13-21 04:05PM] Biolase Stock Jumps On Q1 Earnings Beat, Strong Demand For Dental Lasers, Q2 Outlook [May-14-21 09:20AM] Humanigen Shares Gain On FDA Emergency Filing Plans For COVID-19 Drug By June [May-14-21 09:24AM]
25-03-2021	AH	4:05 PM ET (Mar 25)	BIOL	Biolase, Inc.	141.60	-0.07	-0.04	-0.13	Biolase EPS misses by $0.03, beats on revenue [3/25/2021 4:11 PM]	0.8427	-0.12 (-12.20%)	0.92	-0.04 (-4.36%)	0.21 - 1.51	6,362,212	6,540,000	264,695
Biolase EPS misses by $0.03, beats on revenue [3/25/2021 4:11 PM] BIOLASE, Inc. to Host Earnings Call [Mar-25-21 02:30PM] BIOLASE Reports 31% Sequential Revenue Growth In 2020 Fourth Quarter; Demand From New Users Driving Positive Performance [Mar-25-21 04:05PM]
12-11-2020	AH	4:05 PM ET (Nov 12)	BIOL	Biolase, Inc.	27.99	-0.21	-0.06	-0.25	Biolase EPS misses by $0.16, beats on revenue [11/12/2020 4:10 PM]	0.29	-0.02 (-6.45%)	0.2750	-0.04 (-11.29%)	0.21 - 0.96	2,326,951	1,225,483	188,138

13-08-2020	AH	4:05 PM ET (Aug 13)	BIOL	Biolase, Inc.	21.53	-0.12	-0.20	-0.15	Biolase EPS beats by $0.05, beats on revenue [8/13/2020 4:07 PM]	0.4106	0.01 (2.65%)	0.4070	0.01 (1.75%)	0.21 - 1.46	5,250,426	7,515,797	276,287